跳到主要內容

Ryan Arthur F 的 Form 4 申報

Regeneron Pharmaceuticals, Inc.(REGN),2023/11/8 申報

申報編號
0001968202-23-000039
申報時間
2023/11/8
交易日
2023/11/7
申報延遲
1 天
10b5-1 計畫
有勾選

這份申報列了 8 筆非衍生性交易。公開市場賣出合計 $8.28 萬。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Ryan Arthur FCIK 0001187443董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/11/7Common StockS賣出處分−6$824.59F2−$4,947.5418,641直接
2023/11/7Common StockS賣出處分−18$825.53F3−$14,859.5418,623直接
2023/11/7Common StockS賣出處分−4$826.58F4−$3,306.3218,619直接
2023/11/7Common StockS賣出處分−11$827.65F5−$9,104.1518,608直接
2023/11/7Common StockS賣出處分−39$828.54F6−$32,313.0618,569直接
2023/11/7Common StockS賣出處分−18$829.43F7−$14,929.7418,551直接
2023/11/7Common StockS賣出處分−3$830.39F8−$2,491.1718,548直接
2023/11/7Common StockS賣出處分−1$838.46−$838.4618,547直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Represents volume-weighted average price of sales of 6 shares of Company stock on November 7, 2023 at prices ranging from $824.14 to $824.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents volume-weighted average price of sales of 18 shares of Company stock on November 7, 2023 at prices ranging from $825.04 to $825.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents volume-weighted average price of sales of 4 shares of Company stock on November 7, 2023 at prices ranging from $826.44 to $826.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents volume-weighted average price of sales of 11 shares of Company stock on November 7, 2023 at prices ranging from $827.03 to $827.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents volume-weighted average price of sales of 39 shares of Company stock on November 7, 2023 at prices ranging from $828.01 to $828.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents volume-weighted average price of sales of 18 shares of Company stock on November 7, 2023 at prices ranging from $829.10 to $829.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F8

Represents volume-weighted average price of sales of 3 shares of Company stock on November 7, 2023 at prices ranging from $830.04 to $830.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)